Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests smart glucose monitor for transplant patients

NCT ID NCT04783441

First seen Jan 29, 2026 · Last updated May 25, 2026 · Updated 16 times

Summary

This study looks at whether using a continuous glucose monitor (CGM) can help people who have had a kidney transplant and have type 2 diabetes keep their blood sugar in a healthy range. About 80 adults who received a kidney transplant in the past year and use insulin will wear a CGM device. The goal is to see if this technology improves the time their blood sugar stays in the target zone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UC Davis Health

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.